The adverse reactions listed may also be associated with the underlying disease and/or concomitant medicinal products.
Additional reactions reported from post-marketing experience are included in italics in the list as follows. See Table 2.
Click on icon to see table/diagram/image
After discontinuation of short-term and long-term treatment with Pregabalin withdrawal symptoms have been observed in some patients. The following reactions have been mentioned: insomnia, headache, nausea, anxiety, diarrhea, flu syndrome, convulsions, nervousness, depression, pain, hyperhidrosis and dizziness, suggestive of physical dependence. The patient should be informed about this at the start of the treatment.
Concerning discontinuation of long-term treatment of Pregabalin, data suggest that the incidence and severity of withdrawal symptoms may be dose-related.
View ADR Monitoring Form